Jove
Visualize
Contact Us

Related Experiment Videos

Topical clonidine antinociception.

Ahmet Dogrul1, Tayfun I Uzbay

  • 1Department of Pharmacology, Gulhane Military Academy of Medicine, Etlik-Ankara 06018, Turkey.

Pain
|September 15, 2004
PubMed
Summary

Topical clonidine (an alpha-2 adrenergic agonist) effectively reduces pain by acting locally on nerve endings. This method avoids systemic side effects like sedation and motor impairment, offering a safer pain relief option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recommendations for intra-abdominal infections consensus report.

Ulusal cerrahi dergisi·2017
Same author

The false-positive responses of analgesic drugs to the intradermal serotonin- and compound 48/80-induced scratches as an animal model of itch.

Acta neurobiologiae experimentalis·2016
Same author

Selective 5-HT7 receptor agonists LP 44 and LP 211 elicit an analgesic effect on formalin-induced orofacial pain in mice.

Journal of applied oral science : revista FOB·2016
Same author

Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.

Archives of dermatological research·2016
Same author

The critical role of spinal 5-HT7 receptors in opioid and non-opioid type stress-induced analgesia.

European journal of pharmacology·2015
Same author

Water/oil type microemulsion systems containing lidocaine hydrochloride: in vitro and in vivo evaluation.

Journal of microencapsulation·2014
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Pain Management
  • Neuroscience

Background:

  • Systemic clonidine (an alpha-2 adrenergic agonist) is a potent pain reliever but causes central side effects.
  • Alpha-2 adrenoceptors are present on peripheral and central nerve terminals involved in pain signaling.

Purpose of the Study:

  • To investigate the efficacy and safety of topically administered clonidine for pain relief.
  • To determine if topical clonidine avoids central side effects associated with systemic administration.

Main Methods:

  • Clonidine was applied topically to mouse tails for varying durations.
  • Antinociception was measured using the radiant heat tail-flick test.
  • Motor coordination was assessed with the rota-rod test.
  • Systemic yohimbine and topical ketamine were used to investigate mechanisms.

Main Results:

  • Topical clonidine produced dose- and duration-dependent antinociception, localized to the application site.
  • Systemic yohimbine blocked topical clonidine's antinociceptive effect.
  • Topical clonidine did not impair motor coordination, unlike systemic administration.
  • Repeated topical clonidine induced tolerance, unaffected by topical ketamine.

Conclusions:

  • Topical clonidine provides localized pain relief by activating peripheral alpha-2 adrenoceptors.
  • This administration route bypasses central side effects and motor impairment.
  • Peripheral NMDA receptors do not appear to mediate tolerance to topical clonidine.

Related Experiment Videos